Literature DB >> 26202753

The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis.

Richard Moreau1,2,3,4.   

Abstract

Entities:  

Year:  2014        PMID： 26202753     DOI： 10.1007/s12072-014-9567-z

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  32 in total

1.  Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.

Authors:  Khalid A Tazi; Jean-Jacques Quioc; Véronique Saada; Annie Bezeaud; Didier Lebrec; Richard Moreau
Journal:  J Hepatol       Date:  2006-03-31       Impact factor: 25.083

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

3.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

Authors:  Javier Fernández; Juan Acevedo; Miriam Castro; Orlando Garcia; Carlos Rodríguez de Lope; Daria Roca; Marco Pavesi; Elsa Sola; Leticia Moreira; Anibal Silva; Tiago Seva-Pereira; Francesco Corradi; Jose Mensa; Pere Ginès; Vicente Arroyo
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

4.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.

Authors:  Xavier Ariza; José Castellote; Jaime Lora-Tamayo; Anna Girbau; Sílvia Salord; Rosa Rota; Javier Ariza; Xavier Xiol
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

6.  Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Authors:  Marie de Vos; Bénédicte De Vroey; Béatrice Garcia Garcia; Clothilde Roy; François Kidd; Jean Henrion; Pierre Deltenre
Journal:  Liver Int       Date:  2013-06-03       Impact factor: 5.828

7.  Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.

Authors:  Rubén Terg; Eduardo Fassio; Mónica Guevara; Mariano Cartier; Cristina Longo; Romina Lucero; Cristina Landeira; Gustavo Romero; Nora Dominguez; Alberto Muñoz; Diana Levi; Carlos Miguez; Raquel Abecasis
Journal:  J Hepatol       Date:  2008-02-14       Impact factor: 25.083

8.  Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.

Authors:  Kotaro Miura; Atsushi Tanaka; Takatsugu Yamamoto; Meguru Adachi; Hajime Takikawa
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

9.  Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.

Authors:  Joon Young Song; Seong Ju Jung; Cheong Won Park; Jang Wook Sohn; Woo Joo Kim; Min Ja Kim; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

10.  Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Authors:  Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki Deok Lee; Hong Bin Kim; Myoung-Don Oh; Eui-Chong Kim; Hyo-Suk Lee; Kang Won Choe
Journal:  Korean J Intern Med       Date:  2004-09       Impact factor: 2.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.